Response to Letter Regarding Article, "Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial"

William N. Whiteley*, Douglas Thompson, Peter Sandercock

*Corresponding author for this work

Research output: Contribution to journalLetter


Search results